In the case of GBM also, TOP2A had missense mutations at 5 different locations in 0.79% of the patients on phosphorylation, sumoylation, acetylation, ubiquitination, and methylation PTM sites having diploid copy number alterations. The gene discussed is TOP2A; the disease is glioblastoma.